Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Mike Mackness

Showing results (1-10 of 33) with videos related to

Pageof 4
Sort By:
Annals of Clinical Biochemistry|June 3, 2009
Variability in the measurement of lipoprotein(a) in the British IslesMike Mackness, Elizabeth Hughes,
Free Radical Biology & Medicine|September 30, 2004
Paraoxonase 1 and atherosclerosis: is the gene or the protein more important?Mike Mackness, Bharti Mackness
Expert Opinion on Therapeutic Targets|April 12, 2013
Targeting paraoxonase-1 in atherosclerosisMike Mackness, Bharti Mackness
Annals of Clinical Biochemistry|November 19, 2008
High-density lipoprotein: why all the fuss?Bharti Mackness, Mike Mackness
Clinical Biochemistry|August 23, 2011
Effect of dilution on high-density lipoprotein associated paraoxonase-1 activityMike Mackness, Bharti Mackness
Gene|May 13, 2015
Human paraoxonase-1 (PON1): Gene structure and expression, promiscuous activities and multiple physiological rolesMike Mackness, Bharti Mackness
Advances in Experimental Medicine and Biology|March 12, 2010
Anti-inflammatory properties of paraoxonase-1 in atherosclerosisBharti Mackness, Mike Mackness
Clinical Biochemistry|January 20, 2019
Unexpectedly higher diazoxon hydrolysis by serum paraoxonase-1 in coronary heart diseaseBharti Mackness, Mike Mackness
Current Opinion in Lipidology|June 4, 2020
Epigenetics of paraoxonasesAbdolkarim Mahrooz, Mike Mackness
IUBMB Life|August 5, 2011
Cholesteryl-ester transfer protein enhances the ability of high-density lipoprotein to inhibit low-density lipoprotein oxidationDavid Hine, Bharti Mackness, Mike Mackness
Pageof 4

Showing results (1-10 of 33) with videos related to

Sort By:
Pageof 4
Annals of Clinical Biochemistry|June 3, 2009
Variability in the measurement of lipoprotein(a) in the British IslesMike Mackness, Elizabeth Hughes,
Free Radical Biology & Medicine|September 30, 2004
Paraoxonase 1 and atherosclerosis: is the gene or the protein more important?Mike Mackness, Bharti Mackness
Expert Opinion on Therapeutic Targets|April 12, 2013
Targeting paraoxonase-1 in atherosclerosisMike Mackness, Bharti Mackness
Annals of Clinical Biochemistry|November 19, 2008
High-density lipoprotein: why all the fuss?Bharti Mackness, Mike Mackness
Clinical Biochemistry|August 23, 2011
Effect of dilution on high-density lipoprotein associated paraoxonase-1 activityMike Mackness, Bharti Mackness
Gene|May 13, 2015
Human paraoxonase-1 (PON1): Gene structure and expression, promiscuous activities and multiple physiological rolesMike Mackness, Bharti Mackness
Advances in Experimental Medicine and Biology|March 12, 2010
Anti-inflammatory properties of paraoxonase-1 in atherosclerosisBharti Mackness, Mike Mackness
Clinical Biochemistry|January 20, 2019
Unexpectedly higher diazoxon hydrolysis by serum paraoxonase-1 in coronary heart diseaseBharti Mackness, Mike Mackness
Current Opinion in Lipidology|June 4, 2020
Epigenetics of paraoxonasesAbdolkarim Mahrooz, Mike Mackness
IUBMB Life|August 5, 2011
Cholesteryl-ester transfer protein enhances the ability of high-density lipoprotein to inhibit low-density lipoprotein oxidationDavid Hine, Bharti Mackness, Mike Mackness
Pageof 4